BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34563229)

  • 1. Viability of a MSQOL-54 general health-related quality of life score using bifactor model.
    Giordano A; Testa S; Bassi M; Cilia S; Bertolotto A; Quartuccio ME; Pietrolongo E; Falautano M; Grobberio M; Niccolai C; Allegri B; Viterbo RG; Confalonieri P; Giovannetti AM; Cocco E; Grasso MG; Lugaresi A; Ferriani E; Nocentini U; Zaffaroni M; De Livera A; Jelinek G; Solari A; Rosato R
    Health Qual Life Outcomes; 2021 Sep; 19(1):224. PubMed ID: 34563229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applying multidimensional computerized adaptive testing to the MSQOL-54: a simulation study.
    Giordano A; Testa S; Bassi M; Cilia S; Bertolotto A; Quartuccio ME; Pietrolongo E; Falautano M; Grobberio M; Niccolai C; Allegri B; Viterbo RG; Confalonieri P; Giovannetti AM; Cocco E; Grasso MG; Lugaresi A; Ferriani E; Nocentini U; Zaffaroni M; De Livera A; Jelinek G; Solari A; Rosato R
    Health Qual Life Outcomes; 2023 Jun; 21(1):61. PubMed ID: 37357308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Italian multiple sclerosis quality of life 54 questionnaire.
    Solari A; Filippini G; Mendozzi L; Ghezzi A; Cifani S; Barbieri E; Baldini S; Salmaggi A; Mantia LL; Farinotti M; Caputo D; Mosconi P
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):158-62. PubMed ID: 10406981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
    Rosato R; Testa S; Bertolotto A; Confalonieri P; Patti F; Lugaresi A; Grasso MG; Toscano A; Giordano A; Solari A
    PLoS One; 2016; 11(4):e0153466. PubMed ID: 27078146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Japanese-translated version Multiple Sclerosis Quality of Life-54 instrument].
    Yamamoto T; Ogata K; Katagishi M; Shimizu H; Ogawa M; Yamamura T; Kawai M
    Rinsho Shinkeigaku; 2004 Jul; 44(7):417-21. PubMed ID: 15384701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Indonesian version of multiple sclerosis quality of life-54 (MSQOL-54 INA) questionnaire.
    Estiasari R; Melani S; Kusumawardhani AAAA; Pangeran D; Fajrina Y; Maharani K; Imran D
    Health Qual Life Outcomes; 2019 Jul; 17(1):120. PubMed ID: 31299971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and acceptability of the Multiple Sclerosis Quality of Life-29 questionnaire in an English-speaking cohort.
    Baker G; Nair KPS; Baster K; Rosato R; Solari A
    Mult Scler; 2019 Oct; 25(11):1539-1542. PubMed ID: 29762081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A health-related quality of life measure for multiple sclerosis.
    Vickrey BG; Hays RD; Harooni R; Myers LW; Ellison GW
    Qual Life Res; 1995 Jun; 4(3):187-206. PubMed ID: 7613530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life-testing the reliability of the MSQOL-54 instrument among MS patients.
    Heiskanen S; Meriläinen P; Pietilä AM
    Scand J Caring Sci; 2007 Jun; 21(2):199-206. PubMed ID: 17559438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmatory factor analysis of the Evidence-Based Practice Attitude Scale (EBPAS) in a large and representative Swedish sample: is the use of the total scale and subscale scores justified?
    Santesson AHE; Bäckström M; Holmberg R; Perrin S; Jarbin H
    BMC Med Res Methodol; 2020 Oct; 20(1):254. PubMed ID: 33054717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the bifactor model in resolving dimensionality issues in health outcomes measures.
    Reise SP; Morizot J; Hays RD
    Qual Life Res; 2007; 16 Suppl 1():19-31. PubMed ID: 17479357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Multiple Sclerosis Quality-of-Life Measures: Comparison in a National Sample.
    Moore F; Vickrey B; Fortin K; Lee L
    Can J Neurol Sci; 2015 Jan; 42(1):55-63. PubMed ID: 25586701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality of life assessment in patients with multiple sclerosis].
    Tepavcević DK; Pekmezović T; Drulović J
    Vojnosanit Pregl; 2009 Aug; 66(8):645-50. PubMed ID: 19780420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing measurement invariance of MSQOL-54 across Italian and English versions.
    Giordano A; Testa S; Bassi M; Cilia S; Bertolotto A; Quartuccio ME; Pietrolongo E; Falautano M; Grobberio M; Niccolai C; Allegri B; Viterbo RG; Confalonieri P; Giovannetti AM; Cocco E; Grasso MG; Lugaresi A; Ferriani E; Nocentini U; Zaffaroni M; De Livera A; Jelinek G; Solari A; Rosato R
    Qual Life Res; 2020 Mar; 29(3):783-791. PubMed ID: 31707695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54.
    Rosato R; Testa S; Bertolotto A; Scavelli F; Giovannetti AM; Confalonieri P; Patti F; Chisari CG; Lugaresi A; Pietrolongo E; Grasso MG; Rossi I; Toscano A; Loera B; Giordano A; Solari A
    Mult Scler; 2019 May; 25(6):856-866. PubMed ID: 29761738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Persian version of Community Integration Questionnaire in persons with multiple sclerosis: translation, reliability, validity, and factor analysis.
    Negahban H; Fattahizadeh P; Ghasemzadeh R; Salehi R; Majdinasab N; Mazaheri M
    Disabil Rehabil; 2013 Aug; 35(17):1453-9. PubMed ID: 23330593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample.
    Idiman E; Uzunel F; Ozakbas S; Yozbatiran N; Oguz M; Callioglu B; Gokce N; Bahar Z
    J Neurol Sci; 2006 Jan; 240(1-2):77-80. PubMed ID: 16277993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in patients with multiple sclerosis in Republic of Srpska.
    Tadić D; Dajić V
    Med Glas (Zenica); 2013 Feb; 10(1):113-9. PubMed ID: 23348172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality-of-life assessment in dementia: the use of DEMQOL and DEMQOL-Proxy total scores.
    Chua KC; Brown A; Little R; Matthews D; Morton L; Loftus V; Watchurst C; Tait R; Romeo R; Banerjee S
    Qual Life Res; 2016 Dec; 25(12):3107-3118. PubMed ID: 27318488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difference between generic and multiple sclerosis-specific quality of life instruments regarding the assessment of treatment efficacy.
    Ozakbas S; Akdede BB; Kösehasanogullari G; Aksan O; Idiman E
    J Neurol Sci; 2007 May; 256(1-2):30-4. PubMed ID: 17379247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.